The LAudato Si’ Challenge - Top companies
September 2018
In summer 2018, Hau Therapeutics participated in the global, Vatican-sponsored ‘The Laudato si’ Challenge’, which seeks to sustainably improve the lives of 10 million people forcibly displaced by 2020 through businesses that are sustainable and ethical. Hau Therapeutics was recognized among the top 55 companies and asked to present at the final event in Rome in December. More information about The Laudato si’ Challenge can be found here.
“Helping the World’s Children is All in the family” (Article)
May 2018
In May 2018, Forbes released an article on how their work with UNICEF has deepened several mothers’ commitment to helping vulnerable youths around the world. The article featured the profound impact that the experience with Syrian and Iraqi refugee children and adolescents had on Jennifer Paradis Behle, Founder & CEO of Hau Therapeutics, and formed her and her husband’s resolve to help displaced youths thrive. A link to the article can be found here.
“The Syrian Refugee Crisis and Impact Investing” (Article)
April 2018
Jennifer Paradis Behle, Founder & CEO of Hau Therapeutics, published an article in the Wharton Magazine reporting on a life-changing trip to Jordan and the social impact opportunities that could transform lives. A link to the article can be found here.